FDA Grants Approval for Addyi (flibanserin) in Postmenopausal Women

Dec 17, 2025 - 10:00
 0  2
RALEIGH, N.C., Dec. 15, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced a monumental milestone for women's health: the U.S. Food and Drug Administration (FDA) has approved Addyi (flibanserin 100 mg) for the treatment of Hypoactive Sexual...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0